Page last updated: 2024-10-17

n(1)-methylnicotinamide and Chronic Disease

n(1)-methylnicotinamide has been researched along with Chronic Disease in 3 studies

N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research Excerpts

ExcerptRelevanceReference
"Depression is one of the most common psychiatric disorders, and there is strong demand for developing novel antidepressants with better efficacy and less adverse effects."1.62Antidepressant-like effects of 1-methylnicotinamide in a chronic unpredictable mild stress model of depression. ( Gu, JH; Ji, CH; Jiang, B; Liu, Y; Tang, WQ; Zhang, Y; Zhao, J, 2021)
"Rosacea is a chronic facial dermatosis with a progressive course, which is characterized by the presence of erythema, papules, pustules, telangiectasias and sebaceous gland hyperplasia."1.33Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study. ( Gebicki, J; Sysa-Jedrzejowska, A; Wieczorkowska, M; Wozniacka, A, 2005)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Lai, S1
Ma, Y1
Hao, L1
Ding, Q1
Chang, K1
Zhuge, H1
Qiu, J1
Xu, T1
Dou, X1
Li, S1
Zhao, J1
Zhang, Y1
Liu, Y1
Tang, WQ1
Ji, CH1
Gu, JH1
Jiang, B1
Wozniacka, A1
Wieczorkowska, M1
Gebicki, J1
Sysa-Jedrzejowska, A1

Other Studies

3 other studies available for n(1)-methylnicotinamide and Chronic Disease

ArticleYear
1-Methylnicotinamide promotes hepatic steatosis in mice: A potential mechanism in chronic alcohol-induced fatty liver disease.
    Biochimica et biophysica acta. Molecular and cell biology of lipids, 2023, Volume: 1868, Issue:4

    Topics: Animals; Chronic Disease; Ethanol; Fatty Liver; Fatty Liver, Alcoholic; Mice; Mice, Inbred C57BL; St

2023
Antidepressant-like effects of 1-methylnicotinamide in a chronic unpredictable mild stress model of depression.
    Neuroscience letters, 2021, 01-18, Volume: 742

    Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Chronic Disease; Depression; Dise

2021
Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study.
    Clinical and experimental dermatology, 2005, Volume: 30, Issue:6

    Topics: Administration, Topical; Adult; Chronic Disease; Dermatologic Agents; Facial Dermatoses; Female; Gel

2005